Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,727,000 | 8,279,000 | 5,177,000 | 2,454,000 | 9,309,000 |
| Depreciation Amortization | N/A | 3,460,000 | 2,293,000 | 1,118,000 | 4,462,000 |
| Income taxes - deferred | N/A | 1,237,000 | 807,000 | 383,000 | 1,498,000 |
| Other Working Capital | -2,804,000 | -3,712,000 | -3,808,000 | -3,012,000 | -2,832,000 |
| Other Operating Activity | 5,974,000 | -572,000 | 787,000 | 398,000 | 737,000 |
| Operating Cash Flow | $13,897,000 | $8,692,000 | $5,256,000 | $1,341,000 | $13,174,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,917,000 | 2,956,000 | 1,879,000 | 1,885,000 | -29,000 |
| PPE Investments | -2,564,000 | -1,421,000 | -967,000 | -400,000 | -2,855,000 |
| Net Acquisitions | 558,000 | 1,040,000 | 21,000 | 1,464,000 | -175,000 |
| Purchase Of Investment | 1,131,000 | N/A | N/A | N/A | -204,000 |
| Sale Of Investment | 431,000 | N/A | N/A | N/A | 313,000 |
| Purchase Sale Intangibles | -534,000 | -775,000 | -444,000 | -126,000 | -379,000 |
| Other Investing Activity | -592,000 | -775,000 | -444,000 | -126,000 | -402,000 |
| Investing Cash Flow | $881,000 | $1,800,000 | $489,000 | $2,823,000 | $-3,352,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -107,000 | 2,161,000 | 2,447,000 | 3,191,000 | 596,000 |
| Debt Issued | 6,024,000 | N/A | N/A | N/A | 93,000 |
| Debt Repayment | -2,599,000 | N/A | N/A | N/A | -2,022,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 1,693,000 |
| Common Stock Repurchased | -6,915,000 | -2,616,000 | -1,860,000 | 10,000 | -2,926,000 |
| Dividend Paid | -6,950,000 | -6,810,000 | -6,810,000 | -6,810,000 | -6,203,000 |
| Other Financing Activity | 2,400,000 | -140,000 | -102,000 | -78,000 | 0 |
| Financing Cash Flow | $-8,147,000 | $-7,405,000 | $-6,325,000 | $-3,687,000 | $-8,769,000 |
| Exchange Rate Effect | -295,000 | N/A | 8,000 | 6,000 | 82,000 |
| Beginning Cash Position | 6,687,000 | 6,687,000 | 6,687,000 | 6,687,000 | 5,552,000 |
| End Cash Position | 13,023,000 | 9,641,000 | 6,797,000 | 7,170,000 | 6,687,000 |
| Net Cash Flow | $6,336,000 | $2,954,000 | $110,000 | $483,000 | $1,135,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,897,000 | 8,692,000 | 5,256,000 | 1,341,000 | 13,174,000 |
| Capital Expenditure | -2,624,000 | -1,794,000 | -1,126,000 | -482,000 | -2,903,000 |
| Free Cash Flow | 11,273,000 | 6,898,000 | 4,130,000 | 859,000 | 10,271,000 |